Related Experiment Video
Updated: Nov 27, 2025

28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.7K
Subxiphoid left atrial ablation for atrial fibrillation
Niels Verberkmoes, Jules Olsthoorn1, Michiel Pieraets2
1Department of Cardiothoracic Surgery Maastricht University Medical Center Maastricht, The Netherlands.
Multimedia Manual of Cardiothoracic Surgery : MMCTS
|December 2, 2020
Summary
The convergent procedure offers a definitive treatment for atrial fibrillation by combining surgical and catheter ablation. This hybrid approach creates comprehensive lesions to effectively manage complex arrhythmias.
Area of Science:
- Cardiology
- Cardiac Surgery
- Electrophysiology
Background:
- Atrial fibrillation (AF) management is shifting towards definitive treatments beyond medical options.
- Pulmonary vein isolation is effective for paroxysmal AF but insufficient for persistent forms with structural heart disease.
- Existing ablation strategies may not fully address reentrant circuits in enlarged atria.
Observation:
- The convergent procedure is a hybrid ablation technique for atrial fibrillation.
- It involves minimally invasive surgical ablation of the posterior left atrium, followed by endocardial catheter ablation.
- This staged approach creates comprehensive linear lesions under direct visualization without lung deflation or chest incisions.
Findings:
- The convergent procedure aims to create a complete lesion pattern on the left atrial posterior wall.
- It addresses limitations of pulmonary vein isolation in persistent and longstanding persistent AF.
- The combination of epicardial and endocardial ablation ensures lesion integrity and comprehensive treatment.
Implications:
- This hybrid approach may offer a more effective long-term solution for complex atrial fibrillation.
- It provides a less invasive alternative to traditional open-chest surgeries.
- The convergent procedure could improve outcomes for patients with persistent AF and structural heart disease.

